IRON · Disc Medicine, Inc. · Executive Compensation
$81.16
+2.54 (+3.23%)
At close · Nov 3
Return incl. dividend (before tax)
Market Cap
$3.02B
Shares
38.39M
Volume · Nov 3
1.54M
Avg daily vol (3M)
835.19K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| John Quisel | J.D., Ph.D. President and Chief Executive Officer | $9,986,626 |
| Jean Franchi | Chief Financial Officer | $4,169,143 |
| Pamela Stephenson | M.P.H. Chief Commercial Officer | $4,162,263 |
| William Savage | M.D., Ph.D. Chief Medical Officer | $3,510,483 |
| Jonathan Yu | M.B.A. Chief Operating Officer | $3,485,203 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| John Quisel | J.D., Ph.D. President and Chief Executive Officer | $9,065,924 |
| Jean Franchi | Chief Financial Officer | $5,300,150 |
| Pamela Stephenson | M.P.H. Chief Commercial Officer | $5,205,054 |
| William Savage | M.D., Ph.D. Chief Medical Officer | $3,053,156 |
| Jonathan Yu | M.B.A. Chief Operating Officer | $2,936,021 |
| Joanne Bryce | C.P.A. Former Chief Financial Officer | $2,640,844 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Joanne Bryce | C.P.A. Former Chief Financial Officer | $1,753,815 |
| John Quisel | J.D., Ph.D. President and Chief Executive Officer | $909,100 |
| William Savage | M.D., Ph.D. Chief Medical Officer | $687,740 |
| Jonathan Yu | M.B.A. Chief Operating Officer | $628,005 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| John Quisel | J.D., Ph.D. President and Chief Executive Officer | $1,831,265 |
| William Savage | M.D., Ph.D. Chief Medical Officer | $890,756 |
| Jonathan Yu | M.B.A. Chief Operating Officer | $816,543 |
| Joanne Bryce | C.P.A. Former Chief Financial Officer | $816,543 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| John Quisel | J.D., Ph.D. President and Chief Executive Officer | $1,597,475 |
| Joanne Bryce | Chief Financial Officer | $836,244 |
| William Savage | MD, Ph.D. Chief Medical Officer | $720,599 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jason Meyenburg | Chief Executive Officer and President | $2,071,294 |
| Dr. Marc Uknis | Chief Medical Officer | $1,556,725 |
| Dr. Scott Lauder | Chief Technology Officer | $616,817 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Mona Ashiya, Ph.D. | Class I member of the Board of Directors | Resigned | 2025-10-06 |
| Nadim Ahmed | director | Appointed | 2025-07-14 |
| Jean Franchi | Chief Financial Officer | Appointed | 2024-02-07 |
| Jonathan Yu | Chief Operating Officer | Appointed | 2024-02-07 |
| Jean M. Franchi | principal financial officer and principal accounting officer | Appointed | 2024-02-07 |
| Jean M. Franchi | Chief Financial Officer | Appointed | 2024-02-07 |
| Jay T. Backstrom, M.D., M.P.H. | member of the Board of Directors | Resigned | 2023-04-19 |
| Brian Piekos | officer positions | Resigned | 2022-12-29 |
| Brian Piekos | Chief Financial Officer and Chief Business Officer | Terminated | 2022-12-29 |
| Joanne Bryce, C.P.A | Chief Financial Officer, principal financial officer and principal accounting officer | Appointed | 2022-12-29 |
| William Savage, MD, Ph.D. | Chief Medical Officer | Appointed | 2022-12-29 |
| Georges Gemayel, Ph.D. | Interim President and Chief Executive Officer | Resigned | 2022-12-29 |
| John Quisel | Chief Executive Officer and principal executive officer | Appointed | 2022-12-29 |
| John Quisel | Class III director | Appointed | 2022-12-29 |
| William White | Class III director | Appointed | 2022-12-29 |
| Donald Nicholson | executive chairman of the board | Appointed | 2022-12-29 |
| Mark Chin | Class II director | Appointed | 2022-12-29 |
| Donald Nicholson | Class III director | Appointed | 2022-12-29 |
| Liam Ratcliff | Class II director | Appointed | 2022-12-29 |
| Jay Backstrom | Class I director | Appointed | 2022-12-29 |
| Georges Gemayel, Ph.D. | Class II director | Appointed | 2022-12-29 |
| Kevin Bitterman | Class I director | Appointed | 2022-12-29 |
| Mona Ashiya | Class I director | Appointed | 2022-12-29 |
| Jim Tananbaum, M.D. | director | Resigned | 2022-12-29 |
| Jason Rhodes | director | Resigned | 2022-12-29 |
Leadership
- Georges Gemayel CEO, Board Member
- Jason Meyenburg CEO, Board Member
- John Quisel CEO, Board Member
- Donald Nicholson Chairman, Board Member
- Georges Gemayel, Ph.D. Chairman, Board Member
- Gregg Beloff CFO
- Jean Franchi CFO
- Jean M. Franchi CFO, Chief Accounting Officer
- Joanne Bryce, C.P.A CFO
- Jonathan Yu COO
- Dr. Scott Lauder CTO
- Scott Lauder CTO
- Rahul Khara General Counsel
- Brian Piekos Chief Accounting Officer
- Dan Dubin Board Member
- Deepa Pakianathan Board Member
- Dr. Jim Tananbaum Board Member
- Jay Backstrom Board Member
- Jean George Board Member
- Kevin Bitterman Board Member
- Liam Ratcliff Board Member
- Liam Ratcliffe Board Member
- Mark Chin Board Member
- Mona Ashiya Board Member
- Nadim Ahmed Board Member
- Robert Carey Board Member
- William White Board Member
Key facts
CIK
1816736
CUSIP
254604101
13F (30d)
50 filings
44 filers
Visit website
Investor relations